In vivo experiments revealed that DNMBP-AS1 knockdown significantly promoted CRC tumorigenicity, but this effect was abrogated in experimental groups treated with miR-30a-5p (Fig. 6I, J). Here, DNMBP is linked to colorectal carcinoma.